Showing 9931-9940 of 21392 results for "".
Improving Diagnostic Accuracy in Systemic Mastocytosis
https://reachmd.com/programs/clinicians-roundtable/systemic-mastocytosis-diagnostic-accuracy/50986/When “normal” test results mislead, critical diagnoses can be missed. So how can we improve diagnostic accuracy in systemic mastocytosis? To find out, Dr. Alexandria speaks with Dr. Tracy George, President and Chief Scientific Officer at ARUP Laboratories as well as a Professor of Pathology at the SBuilding the Team: Integrating Immunotherapy Into Multidisciplinary Care
https://reachmd.com/programs/cme/building-the-team-integrating-immunotherapy-into-multidisciplinary-care/60854/Experts explore emerging evidence and multidisciplinary integration of perioperative immunotherapy for resectable, locally advanced HNSCC.The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
https://reachmd.com/programs/project-oncology/the-potential-impact-of-rcc-molecular-subtypes-on-treatment-outcomes/26533/Tune in to hear expert insights on recent research investigating if renal cell carcinoma molecular subtypes impact treatment outcomes.Improving ATTR-CM Care Through Community-Specialist Partnership
https://reachmd.com/programs/heart-matters/attr-cm-care-community-specialist-partnership/49084/Community providers and amyloidosis specialists each play a vital role in diagnosing and managing transthyretin amyloid cardiomyopathy (ATTR-CM). Join Dr. Alex Reyentovich as he explains how this partnership can improve both patient care and diagnosis rates. Dr. Reyentovich is a Professor in the DepHow MR Fingerprinting Is Transforming Epilepsy Imaging, Surgical Evaluation, and Outcome Prediction
https://reachmd.com/programs/practical-neurology/how-mr-fingerprinting-is-transforming-epilepsy-imaging-surgical-evaluation-and-outcome-prediction/39909/Irene Wang, PhD, Cleveland Clinic, Cleveland, OH, describes how MR fingerprinting, a novel quantitative MRI technique, improves lesion detection, tissue characterization, and presurgical evaluation in patients with drug-resistant epilepsy.Investigating the Latest Innovations in IBD
https://reachmd.com/programs/gi-insights/investigating-the-latest-innovations-in-ibd/13471/From new diagnostic tools to novel therapies, find out how IBD care and management have evolved.Spontaneous Intracranial Hemorrhage Secondary to Rare Pial Arteriovenous Fistula Rupture
https://reachmd.com/diseases-diagnoses/stroke/spontaneous-intracranial-hemorrhage-secondary-to-rare-pial-arteriovenous-fistula-rupture/35445/Pial arteriovenous fistulas are rare cerebrovascular malformations most commonly seen in children; however, they can be found in adults, especially in the setting of an intracranial hemorrhage.Genetic Testing Among Women with Breast Cancer Increasing, Can Impact Treatment Decisions
https://reachmd.com/programs/the-jama-report/genetic-testing-among-women-breast-cancer-increasing-can-impact-treatment-decisions/7935/[Read the Article] Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testingImproving Adherence to Topical Regimens
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative
https://reachmd.com/programs/project-oncology/advancing-precision-medicine-in-nsclc-real-world-impact-of-the-predict-initiative/39034/A 2025 study in Chest evaluated PREDICT, a precision medicine program at a large academic-community practice, designed to streamline testing and expand access to personalized treatment for non-small cell lung cancer (NSCLC). Hear from ReachMD's Ryan Quigley as he shares the key impacts of this appro